LATEST NEWS

LJI scientists, in collaboration with researchers from the Institut Pasteur in France, capture new high-resolution view of rabies virus, revealing potential vaccine targets
How softball brings LJI scientists and admin staff together
Holmes has led the charge in intellectual property and regulatory compliance at two renowned biomedical centers
IP Generator, Inc., (“IPG”) and La Jolla Institute for Immunology (“LJI”), based in La Jolla, California, USA, have entered into a Master Collaborative Research and Development Agreement (“this agreement”) dated May 12, 2022.
New investigation reveals the strength of T cell, B cell, and antibody responses over time
LJI research reveals how aggressive T cells can make heart disease even worse
LJI's Lindy Edwards on her double life as a jazz band leader
LJI scientists discover new drug target for severe asthma, fibrosis
Researchers uncover a new strategy to avoid cancer immunotherapy side effects
Chihab explores how T cells find and kill tumors
LJI Postdoctoral Fellow Greet Verstichel on how T cells learn their "fate"